Health Care Access & Coverage | Health Equity
Drug Pricing: Policy and Politics
Virtual Conversation with Benedic N. Ippolito, PhD, Rachel Sachs, JD, MPH, and Mariana Socal, MD, PhD, moderated by Rachel M. Werner, MD, PhD
Read event recap here.
Despite bipartisan agreement that the high cost of drugs must be addressed, proposals to reform the U.S. drug pricing system have languished for years. There’s no shortage of ideas on what to do—Medicare price negotiation, greater price transparency, international reference pricing, patent exclusivity changes, and price controls all have their advocates. But there’s no consensus on how to strike the right balance between making drugs affordable now, and preserving financial incentives for developing new drugs in the future. Our expert panel discussed the policy options for drug pricing, the appropriate roles of government and markets, and prospects for reform in the current political environment.
Supported by the Charles C. Leighton, MD Memorial Lecture Fund.
Associate Scientist, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health
Event Access Info
Please click the link below to join the webinar:
921 4275 3510
+1 301 715 8592
+1 646 558 8656
International numbers available: https://upenn.zoom.us/u/abE7FoKyr3
H.323/SIP room system:
184.108.40.206 (U.S. West)
220.127.116.11 (U.S. East)
Meeting ID: 921 4275 3510